Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2009, Vol. 14 ›› Issue (2): 155-159.

Previous Articles     Next Articles

Anti-inflammatory effects of the compatibility of Radix Asteris and Flos Farfarae

LI Cong1, HUANG Fang1, DOU Chang-gui1, ZHANG Mian2, MA Shi-ping1   

  1. 1Department of TCM Pharmacology, Chinese Pharmaceutical University, 2Key Laboratory ofModern Chinese Medicines of Ministry of Education, China Pharmaceutical University, Nanjing 210038, Jiangsu, China
  • Received:2008-10-17 Revised:2009-02-05 Online:2009-02-26 Published:2020-10-30

Abstract: AIM: To investigate the anti-inflammatory effects of the mixture of the active parts of Radix Asteris (RA) and Flos Farfarae (FF) (1∶1, w/w) and analyze the relation of compatibility between them. METHODS: The anti-inflammatory effects were measured by inhibiting the nitric oxide synthesis in LPS-ac-tivated macrophageshe, inhibitioning of capillary permeability inmice and acute airway inflammation caused by centrated ammonia method in mice.RESULTS: Compared with two individual active parts, the mixture playded a more prominent role in inhibition of capillary permeability in mice (inhibition ratio :45.1 %, 45.3 %, 51.8 %) and acute airway inflammation caused by centrated ammonia method in mice (inhibition ratio :48.0 %, 53.4 %, 61.4 %);furthermore, the same result resided in RA2, FF3 and their mixture in inhibition of nitric oxide synthesis in LPS-activated macrophageshe(P <0.05 or P <0.01).CONCLUSION: The mixture of two active parts of RA and FF can significantly strengthen the anti-inflammatory effect of two individual active parts, indicating that the mixture of two active parts is provided with mutual promotion effect.

Key words: Radix Asteris, Flos Farfarae, compatibility of CTM, anti-inflammatory

CLC Number: